MeVis Medical Solutions AG

XTRA:M3V Voorraadrapport

Marktkapitalisatie: €44.4m

MeVis Medical Solutions Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Marcus Kirchhoff

Algemeen directeur

€327.0k

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO12.7yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur4.2yrs

Recente managementupdates

Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable

Mar 16
Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable

Recent updates

MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation

Nov 30
MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation

Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable

Mar 16
Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable

MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward

Feb 14
MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward

Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?

Feb 22
Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?

MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Feb 01
MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Analyse CEO-vergoeding

Hoe is Marcus Kirchhoff's beloning veranderd ten opzichte van MeVis Medical Solutions's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024n/an/a

€6m

Dec 31 2023n/an/a

€5m

Sep 30 2023€327kn/a

€5m

Jun 30 2023n/an/a

€6m

Mar 31 2023n/an/a

€6m

Dec 31 2022n/an/a

€7m

Sep 30 2022€316kn/a

€8m

Jun 30 2022n/an/a

€7m

Mar 31 2022n/an/a

€6m

Dec 31 2021n/an/a

€5m

Sep 30 2021€307k€298k

€5m

Jun 30 2021n/an/a

€5m

Mar 31 2021n/an/a

€5m

Dec 31 2020n/an/a

€5m

Sep 30 2020€303k€294k

€6m

Jun 30 2020n/an/a

€7m

Mar 31 2020n/an/a

€7m

Dec 31 2019n/an/a

€7m

Sep 30 2019€279k€270k

€8m

Jun 30 2019n/an/a

€8m

Mar 31 2019n/an/a

€9m

Dec 31 2018n/an/a

€8m

Sep 30 2018€249k€240k

€8m

Compensatie versus markt: De totale vergoeding ($USD 354.36K ) Marcus } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 488.36K ).

Compensatie versus inkomsten: De vergoeding van Marcus is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Marcus Kirchhoff (55 yo)

12.7yrs

Tenure

€327,000

Compensatie

Mr. Marcus Kirchhoff has been the Chief Executive Officer, Chairman of the Board and Member of the Executive Board at MeVis Medical Solutions AG since March 1, 2012. Mr. Kirchhoff serves as Vice President...


Bestuursleden

NaamPositieTenureCompensatieEigendom
Shubham Maheshwari
Deputy Chairman of Supervisory Board3.7yrsgeen gegevensgeen gegevens
Sunny Sanyal
Member of Supervisory Board4.2yrsgeen gegevensgeen gegevens
Kimberley Honeysett
Chairperson of Supervisory Board7.7yrsgeen gegevensgeen gegevens

4.2yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van M3V wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).